Cancer Chemotherapy Flashcards

1
Q

First anticancer drug

A

Mustine (nitrogen mustard) for Hodgkin’s lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how do cancer cells alter host cells with regards to control mechanisms for proliferation and differentiation

A
  1. shorter, accelerated cell cycle
  2. excessive proliferation
  3. higher activity of nucleic acid and protein synthesis
  4. altered cell to cell communication
  5. invasive (disrupt normal healthy tissue)
  6. migrate to distinct sites (metastasis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what do cancer cells use for nutrients and metabolic pathways?

A

the same nutrients and metabolic pathways as the host cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

most common cancer in men age 15-35

A

metastatic testicular cancer. thus the importance of testicular palpation by patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

testicular cancer chemotherapy

A

1 round BEP (Bleomycin, Etoposide, Platinol)

3 rounds VIP (Vinblastin, Ifostamide, Platinol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mitomycin C

A

cross links DNA, bifunctional alkylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cytosine arabinoside, hydroxyurea, 6-MP, MTX, 5-FU

A

Blocks DNA synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Etoposide

A

inhibits TOPOISOMERASE II DNA DEGREDATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Vincristine, Vinblastine, Taxanes

A

block MITOTIC SPINDLE FORMATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mechanism of alkylating agents

A

Nitrogen mustards and Nitrosources. impair cell function by forming covalent bonds with the AMINO, CARBOXYL, SULFHYDRYL, and PHOSPHATE groups. the electron rich nitrogen at the N7 position in Guanine is particularly susceptible.

ACTIVE EVEN FOR THE RESTING CELLS IN GO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nitrogen Mustards Mechanism of action

A

CHLOROETHYL SIDE CHAIN undergoes an intermollecular CYCLINIZATION (Sn1) and forms CARBONIUM ION intermediate or transition complex to become strongly electrophillic. Nucleophillic attack of unstable AZIRIDINE RING by electron donor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Effects of alkylation of the 7 nitrogen of Guanine residues in DNA (3)

A
  1. guanine residues are more acidic and enol tautomer is favored. it can mispair with thymine residues during DNA synth, leading to substitution of A-T pair for G-C pair
  2. causes opening of IMIDAZOLE RING or depurination by excision of guanine residue
  3. with bifunctional alkylating agents, the second 2-choloethyl side chain can undergo intermolecular cyclinization and alkylate a second guanine reside, resulting in cross linking of two nucleic acids or linking NA to protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Nitrogen Mustards clinical use and adverse effects

A

used in combo with other drugs for lymphomas and leukemias.

adverse: teratogenic, immunosuppressive, carcinogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mechlorethamine (mustargen, Mustine)

A

nitrogen based analog of mustard gas that was derived from chemical warfare research. first nitrogen mustard used and most reactive. primarily used in combination chemotherapy regiment MOPP (Mechlorethamine+Oncovin (vincristine)+Procarbazine+Prednisone) for treatment of HODGKIN’S DISEASE.
ADVERSE: more toxic to proliferating cells= bone marrow depression, infertility, and GI toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cyclophosphamide (cytoxin, Neosar)

A

Nitrogen mustard. Bioactivation: PRODRUG converted to PHOSPHORAMIDE MUSTARD and ACROLEIN by P450. DNA cross link of N7 Guanine.
CLINICAL USE: non-neoplastic disease, NON-HODGKIN LYMPHOMA, maintenence therapy of ACUTE LYMPHOID LEUKEMIA, breast cancer as adjuvent, carcinoid, neuroblastome
ADVERSE: bone marrow depression, ALOPECIA, GI, hemorrhagic cystitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

IFOSFAMIDE (ifex)

A

Nitrogen Mustard. analog of cyclophosphamide. activated in liver by ring hydroxylation.
USE: multidrug regimen to treat GERM LINE TESTICULAR CANCER, pediatric and adult sarcomas, and many cancers like cervical, lung, bone, ovarian, and breast
ADVERSE: similar toxicity to cyclophosphamide but greater PLATELET SUPPRESSION and severe urothelial damage and internal bleeding when not used with MESNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Nitrosources mechanism of action

A

spontaneous degradation to form 2-chloroethyl carbonium ion and linerate organic isocyanates that attach carbanoyl groups to lyseine residues of proteins (cross linking DNA strands, break DNA strands, and carbamoylate proteins)
ADVERSE: highly carcinogenic and mutagenic; profound, cumulative myelosuppression; renal failure; alopecia; hepatotoxicity; pulmonary toxicity (Bosulfan)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Lomustine (CeeNU) and Semustine (MeCCNU)

A

Nitrosources. effective orally.
USE: important in treatment of BRAIN CANCER (highly lipophillic, crosses BBB). GI neoplasm and alternate drug for Hodgkin’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Streptozotocin

A

Nitrosource. water soluble, not effective orally. methylates DNA and RNA and is particularly toxic to PANCREATIC ISLET CELLS.
USE: insulinoma (pancreatic islet cell carcimnoma and carcinoid, excessive insulin secretion), metastatic cancer of pancreatic islet cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Busulfan

A

only listed alkyl sulfonate (sul=sul). selectively myelosuppression inhibiting granulocytopoeisis.
USE: Chronic Myelogenous Leukemia (CML) and other myeloproliferative diseases.
ADVERSE: myelosuppression. “BUSULFAN LUNG”: rare but fatal pulmonary fibrosis.

21
Q

Antimetabolites

A

structurally similar to endogenous molecules in synthesis of DNA and RNA. act as enzyme inhibitors and are transferred by the enzymes to fake product. effect is to slow down the synthesis of nucleic acids (S PHASE SPECIFIC)
3 general categories:
purine analogs, pyrimidine analogs, folic acid analogs

22
Q

Purine antagonists

A

inhibit purine ring formation (NT interconversion) (6-MP, 6-thioguanine)

23
Q

Pyrimidine antagonists

A

inhibits pyrimidine synthesis (Pala Azaribine)

5-FLUOROURACIL (5-FU): inhibits dTMP synthesis

24
Q

Folate antagonists

A

inhibit dehydrofolate reduction and blocks purine and TMP synthesis (MTX)

25
Q

Cytarabine

A

antimetabolite. cytosine arabinoside. inhibits DNA synthesis.

26
Q

6-mercaptopurine, 6-MP

A

purine antagonist. S phase specific. structural analog to adenine that is activated by HGPRT conversion to a nucleotide (6-TIMP). this inhibits the conversion of IMP to adenine and guanine and blocks the final step of synthesis or purines.
USE: maintenence in acute lymphoid leukemia in children.
ADVERSE: bone marrow suppression, immunosuppression, GI, hepatotoxicity
RESISTANCE: decreased activation (lack of HGPRTase) and increased breakdown of 6-TIMP by alk phos

27
Q

6-thioguanine

A

purine antagonist. S phase specific. enzymatic (HGPRT) conversion to nucleoside (6-TGMP) which is incorporated into DNA as dTGTP.
USE: leukemias, particularly valuable in treating acute granulocytic leukemia when given with cytanabine
ADVERSE: bone marrow suppression, mild nausea
RESISTANCE: decreased conversion of the drug.

28
Q

Methotrexate (MTX)

A

folic acid analog. inhibits DIHYDROFOLATE REDUCTASE, which decreases dTMP leading to decreased DNA and protein synthesis

29
Q

Methotrexate Use

A

leukemias
lymphomas
choriocarcinoma
sarcomas

30
Q

methotrexate toxicity

A

myelosuppression, which is reversible with leucovorin
macrovesicular fatty changes in liver
mucositis
teratogenic

31
Q

5-Fluorouracil

A

pyrimadine analog, bioactivated to 5d-dUMP, which covalently complexes folic acid. this complex inhibits THYMIDYLATE SYNTHASE, which will decrease dTMP, leading to decreased DNA and protein synthesis

32
Q

5-Fluorouracil use

A

colon cancer

blast cell carcinoma

33
Q

5-Fluorouracil toxicity

A

myelsuppression, which is reverse with leucovorin
overdose- rescue with thymidine
photosensitivity

34
Q

Dactinomycin

A

intercalates DNA

35
Q

Doxorubicin (adriamycin), daunorubicon

A

generate free radical. noncovalently intercalate DNA, causing breaks in DNA and decreased replication.
USE: solid tumors, leukemias, lymphomas

36
Q

Doxorubicin (adriamycin), daunorubicon toxicity

A

cardiotoxicity
myelosuppression
alopecia

37
Q

Bleomycin

A

induces free radical formation, which causes breaks in DNA strands

38
Q

Bleomycin use

A

testicular cancer

hodgkins lymphoma

39
Q

Vincristine, Vinblastine

A

Alkaloids that bind to tubulin in M phase and block polymerization of microtubules so that mitotic spindle cannot form. used in solid tumors and leukemia

40
Q

vincristine toxicity

A

neurotoxicity (areflexia, peripheral neuritis)

paralytic ileus

41
Q

vinblastine toxicity

A

BLASTs bone marrow

42
Q

Cisplatan, carboplatin

A

cross link DNA. used in testicular, ovary, and lung carcinoma

43
Q

Cisplatan, carboplatin toxicity

A

nephrotoxicity

acoustic nerve damage

44
Q

Hydroxyurea mechanism

A

inhibits RIBONUCLEOTIDE REDUCTASE, which leads to decreased DNA synthesis.

45
Q

Hydroxyurea use and toxicity

A

used in melanoma, CML, and sickle cell

causes bone marrow suppression and GI irritation

46
Q

Tamoxifen, raloxifene

A

SERMs receptor antagonist in breast and agonist in bones. block binding of estrogen to estrogen receptor positive cells.

47
Q

Herceptin

A

monoclonal antibody against HER-2, a tyrosine kinase. helps kill breast cancer cells that overexpress HER-2. can cause cardiotoxicity

48
Q

Imatinib (Gleevec)

A

philadelphia chromosome bcr-abl tyrosine kinase inhibitor. used in CML and GI stromal tumors

49
Q

Rituximab

A

monoclonal antibody against CD20. used in Non hodgkins lymphoma and RA with methotrexate